Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection

Saved in:
Bibliographic Details
Published in:JAC-Antimicrobial Resistance
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552912980934657
collection WordPress RSS
FRELIP Feed Integration
container_title JAC-Antimicrobial Resistance
description
discipline_display Internal Medicine
discipline_facet Internal Medicine
format Online Article
RSS Article
genre Journal Article
id rss_article:67856
institution FRELIP
journal_source_facet JAC-Antimicrobial Resistance
last_indexed 2026-06-20T21:28:40.759Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection
Internal Medicine
General
Internal Medicine
sub_discipline_display General
sub_discipline_facet General
subject_display Internal Medicine
General
Internal Medicine
subject_facet Internal Medicine
General
Internal Medicine
title Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection
title_alt Análisis farmacocinético de nacubactam, un nuevo inhibidor de β-lactamasas, coadministrado con meropenem en pacientes con infección urinaria complicada
Analyse pharmacocinétique du nacubactam, un nouvel inhibiteur de β-lactamase, co-administré avec le méropénem chez des patients atteints d'une infection urinaire compliquée
Análise farmacocinética de nacubactam, um novo inibidor de β-lactamase, coadministrado com meropenem em pacientes com infecção urinária complicada
title_auth Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection
title_es_txt Análisis farmacocinético de nacubactam, un nuevo inhibidor de β-lactamasas, coadministrado con meropenem en pacientes con infección urinaria complicada
title_fr_txt Analyse pharmacocinétique du nacubactam, un nouvel inhibiteur de β-lactamase, co-administré avec le méropénem chez des patients atteints d'une infection urinaire compliquée
title_full Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection
title_fullStr Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection
title_full_unstemmed Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection
title_pt_txt Análise farmacocinética de nacubactam, um novo inibidor de β-lactamase, coadministrado com meropenem em pacientes com infecção urinária complicada
title_short Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection
title_sort pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection
topic Internal Medicine
General
Internal Medicine
url https://academic.oup.com/jacamr/article/doi/10.1093/jacamr/dlag098/8700452?rss=1